An overview of the potential strategies for NK cell-based immunotherapy for acute myeloid leukemia.

about

An overview of the potential strategies for NK cell-based immunotherapy for acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q38930242

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

An overview of the potential s ...... py for acute myeloid leukemia.

@en

type

Item

label

An overview of the potential s ...... py for acute myeloid leukemia.

@en

prefLabel

An overview of the potential s ...... py for acute myeloid leukemia.

@en

P1476

An overview of the potential s ...... py for acute myeloid leukemia.

@en

P2093

Chandrima Sinha

http://www.w3.org/2001/XMLSchema#string

Lea C Cunningham

http://www.w3.org/2001/XMLSchema#string

P2860

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy

CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)

Utilizing chimeric antigen receptors to direct natural killer cell activity

In search of the 'missing self': MHC molecules and NK cell recognition

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group

Functions of natural killer cells

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

P304

2078-2085

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.26171

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27535002

http://www.w3.org/2001/XMLSchema#string